Text Size
42 studies found for:    parasitic infections niaid | Open Studies

Modify this search | How to Use Search Results

Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Cancel
Rank Status Study
1 Recruiting Parasitic Infections of the Gastrointestinal Tract
Conditions: Amebiasis;   Cryptosporidiosis;   Giardiasis;   Parasitic Disease;   Parasitic Intestinal Disease
Intervention:
2 Recruiting Evaluation and Long-Term Follow-up of Patients With Inflammatory Disorders
Conditions: Bacterial Infection and Mycoses;   Immunologic Disease;   Inflammation;   Parasitic Disease;   Virus Disease
Intervention:
3 Recruiting Activation and Function of Eosinophils in Conditions With Blood or Tissue Eosinophilia
Conditions: Asthma;   Eosinophilia;   Helminthiasis;   Hypersensitivity;   Parasitic Disease
Intervention:
4 Recruiting Evaluation, Treatment and Monitoring of Patients With a Known or Suspected Parasitic Infection
Conditions: Chagas Disease;   Malaria;   Parasitic Disease;   Trypanosomiasis
Intervention:
5 Recruiting A Randomized, Placebo-controlled, Double-blind Pilot Study of Single-dose Humanized Anti-IL5 Antibody (Reslizumab) for the Reduction of Eosinophilia Following Diethylcarbamazine Treatment of Loa Loa Infection
Condition: Loiasis
Interventions: Drug: Reslizumab;   Drug: Diethylcarbamazine
6 Recruiting Comparison of Immune Response in Normal Volunteers and Patients With Helminth Infections
Conditions: Healthy;   Helminthiasis
Intervention:
7 Recruiting Apheresis to Obtain Plasma or White Blood Cells for Laboratory Studies
Conditions: Leukopheresis;   Plasmapheresis
Intervention:
8 Not yet recruiting SCH708980 With and Without AmBisome for Visceral Leishmaniasis
Conditions: Leishmaniasis;   Effects of Immunotherapy
Interventions: Drug: SCH708980 Anti-IL-10 monoclonal;   Drug: AmBisome
9 Recruiting Collection of Biological Material From Pregnant Women in a Malarial Region
Condition: Malaria
Intervention:
10 Unknown † Corticosteroids to Reduce Frequency of Seizures in Neurocysticercosis Patients
Condition: Neurocysticercosis
Interventions: Drug: Albendazole;   Drug: Dexamethasone;   Drug: Omeprazole
11 Recruiting A Phase II, Open Label Trial of a Vaccine (FSME-IMMUN 0.5 mL Baxter) Against Tick-borne Encephalitis (TBE) for NIAID Workers Manipulating Tick Borne Encephalitis Virus (TBEV) in the Laboratory
Conditions: Tick-Borne Encephalitis;   Encephalitis, Tick-Borne;   Tick-Borne Disease;   Glycoprotein E, Flavivirus;   NSI Protein, Flavivirus
Intervention: Biological: FSME-IMMUN 0.5ml Baxter
12 Recruiting Host and Parasite Factors That Influence Susceptibility to Malaria Infection and Disease During Pregnancy and Early Childhood in Ouelessebougou and Bamako, Mali
Condition: Malaria
Intervention:
13 Recruiting Treatment of Patients With Cysticercosis With Praziquantel or Albendazole
Condition: Cysticercosis
Intervention:
14 Not yet recruiting Effect of Filarial Infection on Immune Responses in Latent Tuberculosis
Conditions: Tuberculosis;   Filariasis
Intervention:
15 Recruiting Diagnosis and Treatment of Leishmanial Infections
Condition: Leishmaniasis
Intervention:
16 Recruiting Clinical and Immunologic Monitoring of Patients With Known or Suspected HIV Infection
Conditions: HIV Infections;   AIDS;   Opportunistic Infections
Intervention:
17 Recruiting Malaria Studies in Cambodia
Condition: Malaria
Intervention:
18 Recruiting Plasmodium Falciparum Clearance Rates in Response to Artesunate in Eastern Cambodia
Condition: Malaria
Intervention:
19 Recruiting Normal Immunological Parameters Among Healthy Volunteers in Kambila, Mali
Condition: Malaria
Intervention:
20 Recruiting Testing Alhydrogel as a Potential Malaria Vaccine in Mali
Condition: Malaria
Interventions: Biological: Pfs25-EPA;   Biological: Euvax/Hepatitis B vaccine;   Biological: Menatra/Meningococcal Groups A, C, Y, W-135 vaccine;   Biological: Alhydrogel
To Top

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
† Indicates status has not been verified in more than two years